Professor Julio Licinio
Phone: 08 8128 4701
M.D. School of Medicine, Federal University of Bahia, Brazil
Residency - Internal Medicine, University of São Paulo, São Paulo, Brazil
Fellowship - Medicine/ Endocrinology, Pritzker School of Medicine, The University of Chicago, USA
Internship - Psychiatry (PGY 1), Montefiore Medical Center, Albert Einstein College of Medicine of Yeshiva University, New York, USA
Research-Track Residency - Psychiatry, The New York Hospital - Cornell University, USA
Clinical Associate Psychiatry, Cornell University Medical College, USA
Senior Clinical Associate Psychiatry, Cornell University Medical College, USA
American Board of Psychiatry and Neurology, Certified in Psychiatry
Julio Licinio, M.D., FRANZCP, is Deputy Director for Translational Medicine and Head, Mind and Brain Theme at the South Australian Health and Medical Research Institute (SAHMRI) and Strategic Professor of Psychiatry, Flinders University. He is also a Research Professor at the University of Southern California, in Los Angeles, Clinical Professor of Psychiatry at University of Adelaide and Visiting Professor of Psychiatry at University of Minho, in Braga, Portugal and Professeur Associé at Université de Paris - Descartes. He was previously Professor and Director, John Curtin School of Medical Research, The Australian National University (ANU), and head of the Department of Translational Medicine (2009-2013). Professor Licinio is originally from Brazil and lived for over 25 years in the United States, where he had clinical and research training in endocrinology and psychiatry at University of Chicago, Albert Einstein College of Medicine and Cornell. Professor Licinio is recognised internationally as a leader in translational research in depression and obesity. He has conducted medical research for over 20 years at Yale, NIH, UCLA, University of Miami and at the ANU, with key leadership positions in those institutions. He is also current and founding Editor of three Nature Publishing Group journals, Molecular Psychiatry (Impact Factor: 14.897 number 1 worldwide), The Pharmacogenomics Journal (Impact Factor 5.1) and Translational Psychiatry. Professor Licinio’s translational and genomics research spans the lab and clinic examining obesity, depression, and their interface.
Professor Julio Licinio is
Current Competitive Funding
Professor Licinio is currently funded in the areas of psychiatric genetics and neuropsychopharmacology.
- NHMRC Project Grant APP1070935: “Long-term metabolic effects of stress and antidepressants: a novel translational paradigm of drug-induced obesity.” CIB Prof Julio Licinio.
- Flinders University Faculty of Medicine, Establishment Grant “Depression and obesity: shared biology and its impact on the outcomes of online treatments..” CIA Prof Julio Licinio
- German-Australian Institute of Translational Medicine at the University of Dresden and the Australian National University - German government award University Hospital Carl Gustav Carus Chief Investigators: Julio Licinio (Australia) & Stefan Bornstein (Germany)
- NHMRC Project Grant APP1061072: Prevention at critical points: A randomised
controledtrial of an eheathapplication to prevent depression, suicide risk and anxiety in youth” CIE Prof Julio Licinio
- AstraZeneca ProjectGrant: “Recombinant human leptin treatment of genetically-based leptin deficiency.” CIA Prof Julio Licinio